Photo
Language
English
Title and Department
Professor
Department of Medicine, Division of Genetic Medicine
Professional bio
Georgia L. Wiesner, MD, MS, is a Professor of Medicine in the Division of Genetic Medicine within the Department of Medicine at Vanderbilt University Medical Center. She is Director of the Clinical and Translational Hereditary Cancer Program for the Vanderbilt-Ingram Cancer Center.
As one of the few cancer genetic internists in the country, Dr. Wiesner has devoted her career to understanding the factors that cause cancer susceptibility. Since joining the Vanderbilt faculty in 2012, she has established a comprehensive Hereditary Cancer Clinic for patients and family members who are prone to develop cancer. Dr. Wiesner is a research and teaching mentor for the Medical Genetics Residency program and the Masters of Genetic Counseling training program.
The Wiesner research team is devoted to understanding hereditary cancer susceptibility, particularly in the application of precision medicine and genetic tests are used in clinical medicine as well as various ethical, legal and social aspects of genomic medicine. Dr. Wiesner is leading the FOREST project, a multi-site U01 to implement the use of cancer family history into the electronic medical system to better identify patients who are at risk for hereditary cancer syndromes. She is an active investigator in the eMERGE network that is studying the implementation of genetic tests into patient care. She has also leveraged the use of the hereditary cancer database to identify trends in testing and in phenotype recognition.
Dr. Wiesner is a current member of the Genetic/Familial High Risk Assessment, Colorectal Cancer panel sponsored by the National Comprehensive Cancer Network (NCCN). This committee provides expert opinion in formulating guidelines for care of patient and families with heritable cancer syndromes. She is also a current member of the External Scientific Panel for ClinGen, an NHGRI funded project to build resources for clinical interpretation of genetic variants. Previous service includes the Editor-in-Chief of the Cancer Genetics PDQ Editorial Board at the National Cancer Institute from 2001 to 2005, and the Board of Directors for the American Society of Human Genetics; she is also past president of the board of directors of the American Board of Medical Genetics and past chair of the residency review committee for Medical Genetics.
As one of the few cancer genetic internists in the country, Dr. Wiesner has devoted her career to understanding the factors that cause cancer susceptibility. Since joining the Vanderbilt faculty in 2012, she has established a comprehensive Hereditary Cancer Clinic for patients and family members who are prone to develop cancer. Dr. Wiesner is a research and teaching mentor for the Medical Genetics Residency program and the Masters of Genetic Counseling training program.
The Wiesner research team is devoted to understanding hereditary cancer susceptibility, particularly in the application of precision medicine and genetic tests are used in clinical medicine as well as various ethical, legal and social aspects of genomic medicine. Dr. Wiesner is leading the FOREST project, a multi-site U01 to implement the use of cancer family history into the electronic medical system to better identify patients who are at risk for hereditary cancer syndromes. She is an active investigator in the eMERGE network that is studying the implementation of genetic tests into patient care. She has also leveraged the use of the hereditary cancer database to identify trends in testing and in phenotype recognition.
Dr. Wiesner is a current member of the Genetic/Familial High Risk Assessment, Colorectal Cancer panel sponsored by the National Comprehensive Cancer Network (NCCN). This committee provides expert opinion in formulating guidelines for care of patient and families with heritable cancer syndromes. She is also a current member of the External Scientific Panel for ClinGen, an NHGRI funded project to build resources for clinical interpretation of genetic variants. Previous service includes the Editor-in-Chief of the Cancer Genetics PDQ Editorial Board at the National Cancer Institute from 2001 to 2005, and the Board of Directors for the American Society of Human Genetics; she is also past president of the board of directors of the American Board of Medical Genetics and past chair of the residency review committee for Medical Genetics.